Search research articles
Contact Us
Filters
Showing results (51-60 of 293) with videos related to
Page
of 30
Sort By:
Experimental Dermatology
|
March 3, 2021
Ex vivo gene modification therapy for genetic skin diseases-recent advances in gene modification technologies and delivery
Vignesh Jayarajan, Evangelia Kounatidou, Waseem Qasim, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 4, 2012
Statistical methods for analysis of time-dependent inhibition of cytochrome p450 enzymes
Phillip Yates, Heather Eng, Li Di, et al.
Journal of Medicinal Chemistry
|
January 9, 2020
Dose Predictions for Drug Design
Tristan S Maurer, Dennis Smith, Kevin Beaumont, et al.
International Journal of Pharmaceutics
|
May 7, 2005
Development and application of high throughput plasma stability assay for drug discovery
Li Di, Edward H Kerns, Yan Hong, et al.
Journal of Medicinal Chemistry
|
August 5, 2025
Insights on Volume of Distribution of Acids
Dennis Smith, Kevin Beaumont, Tristan S Maurer, et al.
Seminars in Cell & Developmental Biology
|
November 18, 2017
ADARs and editing: The role of A-to-I RNA modification in cancer progression
Kajsa Fritzell, Li-Di Xu, Jens Lagergren, et al.
Research and Reports in Urology
|
May 19, 2022
A Novel Risk Score (P-score) Based on a Three-Gene Signature, for Estimating the Risk of Prostate Cancer-Specific Mortality
Fabian Söderdahl, Li-Di Xu, Johan Bring, et al.
Journal of Medicinal Chemistry
|
May 7, 2025
Correction to "Dose Predictions for Drug Design"
Tristan S Maurer, Dennis Smith, Kevin Beaumont, et al.
Journal of Medicinal Chemistry
|
November 8, 2017
Relevance of Half-Life in Drug Design
Dennis A Smith, Kevin Beaumont, Tristan S Maurer, et al.
The AAPS Journal
|
December 11, 2024
Prediction of Drug-Drug Interactions for Highly Plasma Protein Bound Compounds
David Tess, Makayla Harrison, Jian Lin, et al.
Page
of 30
Search research articles
Search
Showing results (51-60 of 293) with videos related to
Sort By:
Page
of 30
Experimental Dermatology
|
March 3, 2021
Ex vivo gene modification therapy for genetic skin diseases-recent advances in gene modification technologies and delivery
Vignesh Jayarajan, Evangelia Kounatidou, Waseem Qasim, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 4, 2012
Statistical methods for analysis of time-dependent inhibition of cytochrome p450 enzymes
Phillip Yates, Heather Eng, Li Di, et al.
Journal of Medicinal Chemistry
|
January 9, 2020
Dose Predictions for Drug Design
Tristan S Maurer, Dennis Smith, Kevin Beaumont, et al.
International Journal of Pharmaceutics
|
May 7, 2005
Development and application of high throughput plasma stability assay for drug discovery
Li Di, Edward H Kerns, Yan Hong, et al.
Journal of Medicinal Chemistry
|
August 5, 2025
Insights on Volume of Distribution of Acids
Dennis Smith, Kevin Beaumont, Tristan S Maurer, et al.
Seminars in Cell & Developmental Biology
|
November 18, 2017
ADARs and editing: The role of A-to-I RNA modification in cancer progression
Kajsa Fritzell, Li-Di Xu, Jens Lagergren, et al.
Research and Reports in Urology
|
May 19, 2022
A Novel Risk Score (P-score) Based on a Three-Gene Signature, for Estimating the Risk of Prostate Cancer-Specific Mortality
Fabian Söderdahl, Li-Di Xu, Johan Bring, et al.
Journal of Medicinal Chemistry
|
May 7, 2025
Correction to "Dose Predictions for Drug Design"
Tristan S Maurer, Dennis Smith, Kevin Beaumont, et al.
Journal of Medicinal Chemistry
|
November 8, 2017
Relevance of Half-Life in Drug Design
Dennis A Smith, Kevin Beaumont, Tristan S Maurer, et al.
The AAPS Journal
|
December 11, 2024
Prediction of Drug-Drug Interactions for Highly Plasma Protein Bound Compounds
David Tess, Makayla Harrison, Jian Lin, et al.
Page
of 30